We are live on ! Find out more
HUMA icon

Humacyte
HUMA

123 hedge funds and large institutions have $150M invested in Humacyte in 2024 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 51 increasing their positions, 14 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

264% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 14

171% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 17

107% more capital invested

Capital invested by funds: $72.4M → $150M (+$77.4M)

28% more funds holding

Funds holding: 96 → 123 (+27)

6.3% more ownership

Funds ownership: 19.91% → 26.2% (+6.3%)

8% less call options, than puts

Call options by funds: $3.34M | Put options by funds: $3.61M

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
123
Holders Change
+27
Holders Change %
+28.13%
% of All Funds
1.78%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
46
Increased
51
Reduced
14
Closed
17
Calls
$3.34M
Puts
$3.61M
Net Calls
-$272K
Net Calls Change
+$483K

Top Buyers

1
BlackRock
BlackRock
New York
+$12.2M
2
State Street
State Street
Massachusetts
+$8.62M
3
Millennium Management
Millennium Management
New York
+$6.95M
4
N
Nuveen
North Carolina
+$6.05M
5
Two Sigma Investments
Two Sigma Investments
New York
+$5.81M

Top Sellers

1
ACM
AIGH Capital Management
Maryland
-$6.71M
2
SCM
Sio Capital Management
New York
-$6.22M
3
MIM
Monashee Investment Management
Massachusetts
-$3.75M
4
PGP
Prescott General Partners
Florida
-$1.77M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
AWM
101
Avior Wealth Management
Nebraska
$4.8K -$62 -12 -1%
AA
102
Addison Advisors
Vermont
$4.8K – – –
CFGS
103
Concourse Financial Group Securities
Alabama
$4.8K +$5.21K +1,000 New
EAM
104
Eukles Asset Management
Ohio
$4.8K +$5.21K +1,000 New
PS
105
Principal Securities
Iowa
$4.8K +$5.21K +1,000 New
AAP
106
Arax Advisory Partners
Colorado
$3.76K +$4.08K +783 New
Pacer Advisors
107
Pacer Advisors
Pennsylvania
$2.85K +$3.09K +593 New
MFG
108
Mendota Financial Group
Wisconsin
$2.4K – – –
Fifth Third Bancorp
109
Fifth Third Bancorp
Ohio
$2.4K +$2.6K +500 New
WWM
110
Wolff Wiese Magana
California
$2.4K +$2.6K +500 New
Russell Investments Group
111
Russell Investments Group
United Kingdom
$1.81K +$1.97K +378 New
AF
112
Allworth Financial
California
$1.51K – – –
Daiwa Securities Group
113
Daiwa Securities Group
Japan
$1K – – –
BFS
114
Bare Financial Services
Pennsylvania
$984 +$541 +104 New
Nisa Investment Advisors
115
Nisa Investment Advisors
Missouri
$970 +$416 +80 +66%
HCP
116
Hexagon Capital Partners
Arkansas
$960 +$1.04K +200 New
IA
117
IFP Advisors
Florida
$960 +$1.04K +200 New
SWC
118
Spectrum Wealth Counsel
Indiana
$960 +$1.04K +200 New
GI
119
GAMMA Investing
California
$758 +$239 +46 +41%
HPC
120
HM Payson & Co
Maine
$480 +$520 +100 New
RIL
121
Rothschild Investment LLC
Illinois
$312 +$338 +65 New
BFS
122
Burkett Financial Services
South Carolina
$86 +$94 +18 New
OP
123
ORG Partners
Indiana
$26 +$26 +5 New
ACM
124
AIGH Capital Management
Maryland
– -$6.71M -2,155,958 Closed
SCM
125
Sio Capital Management
New York
– -$6.22M -2,000,000 Closed
2 3 4
5
6

HUMA Hedge Fund Activity: Q2 2024 in Review

123 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q2 2024, worth a combined $150M — up 107% from $72.4M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new HUMA positions and 17 closed out — a net gain of 29 holders — while 51 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $12.2M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $6.71M sold.

  • 123 institutional investors held Humacyte (HUMA) as of Q2 2024, up from 96 in Q1 2024.
  • Funds reported $150M of Humacyte stock for Q2 2024, up 107% quarter-over-quarter.
  • 46 funds opened new Humacyte positions in Q2 2024 and 17 closed out, a net change of +29 holders.
  • The largest Humacyte buyer in Q2 2024 was BlackRock, an estimated $12.2M added.
  • The largest Humacyte seller in Q2 2024 was AIGH Capital Management, an estimated $6.71M sold.

Based on aggregated 13F filings for Q2 2024.